Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.

Hilleman Laboratories' Synthetic Vaccine to Fight Growing Meningitis

Date: 26/10/2015

Hilleman Laboratories Pvt. Ltd, India, Vaccine Asia Pacific 2015

Date: 13/10/2015

Hilleman Laboratories Mr. Naveen Amar honoured as ‘100 most influential C

Date: 03/08/2015

Game Changer In Vaccine Storage

Date: 30/06/2015

Hilleman Laboratories’ preclinical trial report on Hib vaccine offers hop

Date: 24/06/2015

We are developing vaccines that can be stored at 45 degree Celsius

Date: 21/05/2015

Thermostable boost for vaccines on cards

Date: 30/04/2015

India explores 'heatproof' vaccines to stop vital medicines going to waste

Date: 29/04/2015

Hilleman Laboratories’ Thermostable technology now extends its support to

Date: 24/04/2015

Hilleman Laboratories hosts workshop on ‘Innovation in Vaccine Manufactur

Date: 04/02/2015

Hilleman Laboratories renews agreement with Jamia Hamdard University cement

Date: 13/12/2014

Hilleman Laboratories signs MoU to fast track development of high-impact Or

Date: 10/11/2014

Hilleman Laboratories advances its Rotavirus Program for improved vaccine a

Date: 04/09/2014

MOU signed between Hilleman Laboratories and Jamia Hamdard

Date: 30/08/2014

Hilleman Laboratories on India Business Hour CNBCTV18

Date: 25/06/2014